Company Analysis

Biomea Fusion, Inc. (BMEA)

Nasdaq: BMEA · Pharmaceutical Preparations · San Carlos, CA · filing with the SEC since 2021
Grade5.1
◀ Past 4.7● Present 3.6▶ Future 6.6
6 est.

Who runs Biomea Fusion, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Hitchcock Michael J.M.
Interim CEO. First filing Apr 2021, latest Apr 3, 2026, 3 filings in all.
Officers reporting now
2
of 8 people with a filing in the last fifteen months
Directors reporting now
6
13 people on the record since 2021
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Hitchcock Michael J.M.Interim CEOApr 2021Apr 3, 2026none
Erdtmann Rainer MPresident, Chief Operating Officer, Principal Financial Officer, and Principal Accounting OfficerApr 2021Apr 3, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Aguiar EricdirectorApr 2021Jun 12, 2026none
Averill JuliannedirectorJul 2025Jun 12, 2026none
Faust ElizabethdirectorJun 2022Jun 12, 2026none
Ray SumitadirectorJun 2021Jun 12, 2026none
Chen BihuadirectorApr 2021Aug 1, 2025none
Cormorant Asset Management, LPdirectorApr 2021Aug 1, 2025none
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Cormorant Global Healthcare Master Fund, LP10% ownerApr 2021Aug 1, 2025none
Cormorant Private Healthcare Fund III LP10% ownerApr 2021Aug 1, 2025none
Earlier names on the record7, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton BMEA · research, not advice